These observations could have translational application for personalized medicine approaches, as they suggest that specific cytokine-targeted therapies may have improved efficacy in HLA-DRB1+ individuals with relevant occupational exposures and lung disease manifestations. The gene discussed is HLA-DRB1; the disease is lung disorder.